NEURALSTUDIO SEZC – Trademark Portfolio
Entity Type: 11
NEURALSTUDIO SEZC holds 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 10 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 6 trademarks are registered. Notable registered marks include NEURALWARE, NEURALPOWER, NEURALWORKS, NEURALSTUDIO, and NEURALWORKS PREDICT. The owner is based in GRAND CAYMAN.
Cayman Enterprise City
PO Box 10315, 90 N. Church St.
GRAND CAYMAN KY1-1003 , KY
Showing of trademarks Trademarks
Trademark Classifications
NEURALSTUDIO SEZC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does NEURALSTUDIO SEZC have?
NEURALSTUDIO SEZC has 10 U.S. trademarks filed with the USPTO. Of these, 6 registered, 4 cancelled.
What trademark classes does NEURALSTUDIO SEZC file in?
NEURALSTUDIO SEZC files trademarks across 2 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are NEURALSTUDIO SEZC's most well-known trademarks?
NEURALSTUDIO SEZC's registered trademark portfolio includes well-known marks such as NEURALWARE, NEURALPOWER, NEURALWORKS, NEURALSTUDIO, and NEURALWORKS PREDICT. These are among 6 currently registered trademarks in the portfolio.
What is NEURALSTUDIO SEZC's trademark registration success rate?
NEURALSTUDIO SEZC has a 60% trademark registration rate, with 6 out of 10 resolved applications resulting in successful registration. Currently, 0 applications are pending review.